Microvascular and C-fiber function in diabetic Charcot neuroarthropathy and diabetic peripheral neuropathy

被引:21
|
作者
Baker, Neil
Green, Alistair
Krishnan, Singhan
Rayman, Gerry
机构
[1] Ipswich Diabet Food Unit, Ipswich, Suffolk, England
[2] Ipswich Diabet Ctr, Ipswich, Suffolk, England
关键词
D O I
10.2337/dc07-1063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Sympathetic denervation and hyperemia are implicated in the pathogenesis of Charcot neuroarthropathy (CN) but are also features of diabetic peripheral neuropathy (DPN). Differences in these physiological parameters were sought by determining C-fiber function (laser Doppler imager [LDI]flare technique) and maximum microvascular hyperemia (MMH) in 13 subjects with diabetic CN (DCN), 10 subjects with DPN, and 10 healthy control subjects. Additionally, unaffected limbs of the nine DCN subjects with unilateral CN (UCN) were studied to determine whether any observed differences precede CN. RESULTS - LDIflare area was reduced in DPN (mean +/- SD 1.41 +/- 0.51 cm(2)) and DCN (1.42 +/- 0.37) groups compared with the healthy control group (5.24 +/- 1.33; P < 0.0001). MMH was higher in DCN (432 88 PU [perfusion units]) than in DPN (262 +/- 71; P = 0.001) subjects but lower than in the control group (564 112; P < 0.01). LDIflare area and MMH were similar in the UCN and DCN groups. CONCLUSIONS - C-fiber function is equally impaired in neuropathic patients with and without CN; however, a higher MMH distinguishes those with CN. Unaffected and affected limbs of those with unilateral CN have the same neurovascular abnormalities, suggesting that these abnormalities precede CN and are not a result of CN.
引用
收藏
页码:3077 / 3079
页数:3
相关论文
共 50 条
  • [41] Sudomotor function in diabetic peripheral artery disease: a role for diabetic neuropathy?
    Pauline Poupon
    Marie Monlun
    Laure Alexandre
    Laurence Blanco
    Vincent Rigalleau
    Neurological Sciences, 2018, 39 : 191 - 192
  • [42] Internal Amputation in Charcot Neuroarthropathy Complicated by Diabetic Foot Osteomyelitis
    Consul, Devon
    So, Eric
    Shah, Nisha
    Logan, Daniel
    JOURNAL OF FOOT & ANKLE SURGERY, 2020, 59 (04): : 853 - 856
  • [43] An overview of conservative treatment options for diabetic Charcot foot neuroarthropathy
    Ramanujam, Crystal L.
    Facaros, Zacharia
    DIABETIC FOOT & ANKLE, 2011, 2 (01): : 1 - 5
  • [44] A study of extracellular vesicle concentration in active diabetic Charcot neuroarthropathy
    Schara, K.
    Stukelj, R.
    Krek, J. L.
    Lakota, K.
    Sodin-Semrl, S.
    Boulton, A. J. M.
    Kralj-Iglic, V.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 98 : 58 - 63
  • [45] Pamidronate in diabetic charcot neuroarthropathy: A randomised placebo controlled trial
    Jude, EB
    Page, S
    Donohue, M
    Foster, A
    Edmonds, M
    Mawer, B
    Adams, J
    Selby, P
    Boulton, AJM
    DIABETOLOGIA, 2000, 43 : A16 - A16
  • [46] Dynamic of bone turnover markers in chronic diabetic Charcot neuroarthropathy
    Shepelekevich, AP
    Zabarovskaya, ZV
    Romeiko, DI
    Tolkachev, JV
    BONE, 2005, 36 : S335 - S335
  • [47] CHARCOT SPINE DUE TO DIABETIC NEUROPATHY
    ZUCKER, G
    MARDER, MJ
    AMERICAN JOURNAL OF MEDICINE, 1952, 12 (01): : 118 - 124
  • [48] Pamidronate in diabetic Charcot neuroarthropathy: A randomised placebo controlled trial
    Jude, E
    Page, S
    Donohoe, M
    Foster, A
    Edmonds, M
    Mawer, B
    Adams, J
    Selby, P
    DIABETES, 2000, 49 : A32 - A33
  • [49] The Charcot Foot as a Complication of Diabetic Neuropathy
    Janice V. Mascarenhas
    Edward B. Jude
    Current Diabetes Reports, 2014, 14
  • [50] The Charcot Foot as a Complication of Diabetic Neuropathy
    Mascarenhas, Janice V.
    Jude, Edward B.
    CURRENT DIABETES REPORTS, 2012, 14 (12) : 561 - U99